Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.43 -0.03 (-0.33%)
As of: Oct 21, 2026 · 10:19 AM EDT

Fennec Pharmaceuticals (FENC) Short term Debt (2022)

Updated

Fennec Pharmaceuticals' Short term Debt came in at $1 million for Q2 2022, up 100.0% from the prior quarter.

Analysis

Fennec Pharmaceuticals (FENC) Short term Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn
10 Fennec Pharmaceuticals 360.13 Mn 241.44 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1.00 Mn
Mar 31, 2022 500,000.00
API Access

Fennec Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FENC&period=max&api_key=YOUR_API_KEY